United States · Bill · S
S. 959 (113th)
Pharmaceutical Quality, Security, and Accountability Act
Introduced
15 May 2013
Last action
—
Status
Placed on Senate Legislative Calendar under General Orders. Calendar No. 89.
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Pharmaceutical Compounding Quality and Accountability Act - Sets forth provisions to revise the regulations regarding human compounding. Establishes requirements for animal drug compounding and biological product compounding. Requires the compounding manufacturers to: (1) register with the Secretary of Health and Human Services (HHS) annually, (2) report to the Secretary on the drugs it compounds, and (3) report serious adverse events associated with the use of compounded drugs. Requires the Secretary to assess establishment and reinspection fees.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
6 official files
Reported to Senate (text)
Reported to Senate · EN · 19 June 2013
Reported to Senate (PDF)
Reported to Senate · EN · 19 June 2013
Reported to Senate with amendment(s)
summary · EN · 19 June 2013
Introduced in Senate (text)
Introduced in Senate · EN · 15 May 2013
Introduced in Senate (PDF)
Introduced in Senate · EN · 15 May 2013
Introduced in Senate
summary · EN · 15 May 2013
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/113th-congress/senate-bill/959
- Open data entity: https://api.congress.gov/v3/bill/113/s/959